Elgene Chemical   Report issue

For profit Phase 3
Founded: Hamden CT United States (2004)
Status: Left NME R&D (2015)

Organization Overview

First Clinical Trial
2005
NCT00166452
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now